Related Experiment Video
Updated: Aug 14, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Vaccination against middle-ear bacterial and viral pathogens
1Department of Pediatrics and Otolaryngology, University of Minnesota School of Medicine, Minneapolis 55455, USA. giebi001@maroon.tc.umn.edu
Annals of the New York Academy of Sciences
|June 9, 1998
Summary
Preventing otitis media (OM) in children is possible through immunization. Vaccines targeting pneumococcus and Haemophilus influenzae, alongside viral vaccines and passive immunoprophylaxis, show promise for reducing OM incidence.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Otitis media (OM) is a common childhood illness with significant public health implications.
- Systemic immunization strategies show considerable promise for preventing OM.
- Existing conjugate vaccine technology, like that for Haemophilus influenzae type b (Hib), provides a foundation for developing new OM vaccines.
Purpose of the Study:
- To review current and emerging strategies for preventing otitis media (OM) through immunization.
- To evaluate the potential of various vaccine candidates, including bacterial conjugate vaccines, viral vaccines, and passive immunoprophylaxis, for OM prevention.
- To explore the challenges and prospects of developing effective OM vaccines.
Main Methods:
- Review of existing literature and clinical trial data on OM prevention strategies.
- Analysis of vaccine antigen potential, including pneumococcal and nontypable Haemophilus influenzae (NTHi) antigens.
- Assessment of viral vaccine efficacy and passive immunoprophylaxis approaches.
Main Results:
- Pneumococcal conjugate vaccines are under development to provide durable immunity in young children.
- Potential vaccine antigens for NTHi, Moraxella catarrhalis, and viral pathogens are being investigated.
- Clinical trials with killed influenza vaccines demonstrated a significant reduction in OM.
- Passive immunoprophylaxis using immune globulins showed protective effects against pneumococcal OM and RSV infections.
Conclusions:
- Vaccine development for OM is progressing, with conjugate vaccines and viral vaccines showing promise.
- Passive immunoprophylaxis offers a potential preventive strategy, particularly for high-risk populations and those with immune deficiencies.
- Further research is needed to identify optimal antigens and delivery methods for widespread OM prevention.
Related Concept Videos
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...